Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 46.50 Delayed Data As of Jul 02 |  -1.75 / -3.63%Today’s Change | 8.49 Today|||52-Week Range 62.97 | +327.78% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $905.7M |
Company Description
Arcturus Therapeutics Holdings, Inc. engages in the research and development of medical applications for the nucleic acid-focused technology. The firm develops RNA therapeutics which focuses on the treatment of liver and respiratory diseases. Its pipeline include LUNAR-OTC and LUNAR CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Contact Information
Arcturus Therapeutics Holdings, Inc. 10628 Science Center Drive San Diego California 92121 |
Employees
Shareholders
| Other institutional | 9.68% |
| Mutual fund holders | 17.87% |
| Individual stakeholders | 12.73% |
Top Executives
| There are no executives to display. |
